| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 114.04B | 106.86B | 98.54B | 85.42B | 85.02B |
| Gross Profit | 28.92B | 25.21B | 21.17B | 19.55B | 19.14B |
| EBITDA | 15.61B | 12.54B | 9.12B | 7.45B | 7.59B |
| Net Income | 11.59B | 8.50B | 5.35B | 4.08B | 4.50B |
Balance Sheet | |||||
| Total Assets | 172.22B | 166.24B | 165.29B | 146.02B | 134.09B |
| Cash, Cash Equivalents and Short-Term Investments | 10.96B | 11.29B | 11.80B | 8.41B | 6.40B |
| Total Debt | 15.51B | 19.21B | 18.71B | 17.53B | 11.95B |
| Total Liabilities | 57.88B | 63.61B | 68.47B | 56.66B | 47.34B |
| Stockholders Equity | 114.34B | 102.62B | 96.82B | 89.35B | 86.74B |
Cash Flow | |||||
| Free Cash Flow | 2.62B | 1.81B | 4.15B | 25.00M | 301.00M |
| Operating Cash Flow | 7.87B | 5.78B | 6.77B | 1.72B | 2.10B |
| Investing Cash Flow | -2.73B | -4.50B | -2.98B | -3.60B | -2.34B |
| Financing Cash Flow | -6.55B | -1.60B | -338.00M | 3.91B | -6.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥98.67B | 8.61 | ― | 3.49% | 6.75% | 36.35% | |
72 Outperform | ¥3.38T | 10.36 | 11.29% | 0.74% | 9.52% | 22.53% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥542.78B | 11.80 | 13.92% | 1.50% | 4.11% | -30.52% | |
62 Neutral | ¥1.24T | 11.26 | 11.29% | 3.00% | 8.07% | 15.81% | |
60 Neutral | ¥4.18T | 35.96 | 7.85% | 1.69% | 6.83% | 10.68% | |
58 Neutral | ¥609.01B | 15.20 | 8.51% | 2.96% | -0.94% | -26.46% |